$RENE #ReNeuron Group ReNeuron Group - Strong data in retinal therapy shows long effects: ReNeuron has released further follow-up data from the ongoing human retinal progenitor cell (hRPC) trial, which shows a robust sustained averaged… https://t.co/Vbgz26ZvBQ #equity #stocks https://t.co/pLjMQlPiDD